About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study of Disease Progression and Anti-HIV Treatments

NCT00001068·41 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

National Institute of Allergy and Infectious Diseases (NIAID)

Age

12–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients must have:
Prior participation on protocol ACTG 175.
PER AMENDMENT 8/27/96:
Patients must be on study/on treatment at the time the protocol study treatment is extended.

The record

StatusCompleted

PhasePhase 2

Taking part210

Started—

UpdatedNov 4, 2021

Conditions

Where41

Alabama Therapeutics CRS
Birmingham, Alabama, United States
USC CRS
Los Angeles, California, United States
UCLA CARE Center CRS
Los Angeles, California, United States

Clareo Health | A Study of Disease Progression and Anti-HIV Treatments